Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-13 Purchase | 2022-06-17 4:14 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 88,154 | $3.0912 | $272,506 | 1,741,894 (Indirect Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 4:10 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 400,000 | $0.985 | $394,000 | 16,531,891 (Indirect Direct) | View |
| 2021-08-18 Purchase | 2021-08-20 4:27 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 480,000 | $1.2788 | $613,800 | 16,137,413 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-03-30 4:52 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 3,000,000 | $2.05 | $6,150,000 | 15,657,413 (Indirect Direct) | View |
| 2020-11-20 Purchase | 2020-11-24 5:39 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 227,471 | $2.1464 | $488,239 | 13,037,413 (Indirect Direct) | View |
| 2020-07-22 Purchase | 2020-07-24 4:03 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 4,152,426 | $1.9 | $7,889,609 | 12,809,942 (Indirect Direct) | View |
| 2020-05-19 Purchase | 2020-05-21 5:01 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 86,265 | $2.2525 | $194,316 | 8,657,516 (Indirect Direct) | View |
| 2020-05-15 Purchase | 2020-05-19 5:55 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 438,932 | $1.9744 | $866,643 | 8,571,251 (Indirect Direct) | View |
| 2020-03-27 Purchase | 2020-03-30 4:01 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 6,880 | $2.08 | $14,310 | 8,132,319 (Indirect Direct) | View |
| 2020-03-25 Purchase | 2020-03-27 5:07 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 524,493 | $2.0338 | $1,066,731 | 8,125,439 (Indirect Direct) | View |
| 2020-03-17 Purchase | 2020-03-19 5:39 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 1,000,002 | $1.5264 | $1,526,444 | 7,600,946 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-15 Option Award | 2021-06-16 4:01 pm | N/A 2031-04-27 | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 4,000,000 | $0 | 4,000,000 (Direct) | View |
| 2020-12-22 Gift | 2020-12-23 4:02 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 380,000 | $0 | 12,657,413 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 4:01 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 374,321 | $1.69 | 6,600,944 (Indirect) | View |
| 2019-12-16 Exercise | 2019-12-18 4:01 pm | 2017-01-02 2020-01-02 | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 374,321 | $0 | 6,600,944 (Indirect) | View |